Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,556.37
(
-0.37%
)
US TECH 100
23,539.96
(
0.08%
)
Dow Jones
46,124.06
(
-0.18%
)
Brent Oil
96.46
(
-0.35%
)
Bitcoin
70,303.00
(
-0.84%
)
News Focus
News Focus
Post# of 19309
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122807
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: croumagnon post# 273

Thursday, 08/03/2006 1:07:21 PM

Thursday, August 03, 2006 1:07:21 PM

Post# of 19309
>Aren't [Merrimack] a bit behind the original guidance on that?<

Only slightly. Merrimack’s guidance for the phase-2b RA results has been “midyear.”

>I am also surprised that a hostile takeover attempt has not happened at these oversold prices.<

A hostile takeover is one thing you do not need to worry about, IMO. When was the last time a hostile takeover occurred in biotech?

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today